Status:
RECRUITING
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborating Sponsors:
Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions:
Post Coronary Artery Bypass Grafting
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-CABG (c...
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years.
- History of CABG surgery or PCI with history of hypertension, diabetes, and dyslipidemia.
- At least one of the following criteria is meet:
- Systolic blood pressure no less than 130 mmHg or diastolic blood pressure no less than 80 mmHg
- HbA1c no less than 7%
- LDL-C no less than 1.4 mmol/L
- Use of a smartphone.
- Signed informed consent.
Exclusion Criteria:
- History of heart failure or severe arrhythmias.
- Presence of other severe underlying conditions such as cancer or liver and kidney insufficiency.
- Pregnancy, lactation, or plans for pregnancy within the next year.
- Cognitive, communication impairments, or limitations in daily activities.
Key Trial Info
Start Date :
September 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2026
Estimated Enrollment :
536 Patients enrolled
Trial Details
Trial ID
NCT06615609
Start Date
September 24 2025
End Date
November 15 2026
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinjiang's First Affiliated Hospital of medical university
Ürümqi, Xinjiang, China, 102300